info@invisionmedi.com
GLATIX-80 Tablets
Controling Diabetes to Prevent CVD
COMPOSITION – Gliclazide 80 mg
Description
Gliclazide
- Sulfonylurea/ SUs (insulin secretagogues)
- The experts opined that among the SUs, gliclazide provides effective glycemic control, has a low risk of hypoglycemia, does not cause weight gain, has renal safety, and provides treatment durability.
- Inhibits the increased adhesiveness of Diabetic monocytes to endothelial cells & reduces the production of TNF-alpha.
- Regarded as a novel carrier in the construction of PVC-based La (III)-selective membrane.
- Improved glycemic control and aids in the prevention of both microvascular & macrovascular complications.
- Safe and potent drug especially in patients with Ischemic heart disease.
Composition
Gliclazide 80 mg
Indications
- Type 2 Diabetes
Related products
-
TENLIFAST-M 500SR / 1000SR Tablets
Prevent Diabetic Complications & Acquire Functional Hemodynamic Indices COMPOSITION – Teneligliptin Hydrobromide Hydrate eq. to Teneligliptin 20 mg + Metformin Hydrochloride IP 500 mg (SR) Teneligliptin Hydrobromide Hydrate eq. to Teneligliptin 20 mg + Metformin Hydrochloride IP 1000 mg (SR)
-
ZIVALIO-M 500ER Tablets
For better Diabetic Outcomes COMPOSITION – Zivalio-M 500 ER Dapagliflozin 10mg + Metformin HCL IP 500mg Tablets
-
REVOSART-A Tablets
A single-pill combination with a promising clinical impact on hypertension COMPOSITION – Telmisartan 40 mg + Amlodipine Besilate 5 mg
-
GLITRAC-M Tablets
For Overall Dual Protection COMPOSITION – Glibenclamide 5 mg + Metformin HCI 500 mg